Wednesday 2 November 2022, 17.00 - 18.00

****Registration for this event is now closed, for registration enquiries please email laurabacchus@onenucleus.com****

 

In association with Fish & Richardson. IP due diligence requires skilled IP counsel to advise on how to be compliant and how best to avoid falling foul of the implications if you do fall short and is vital to the success of sustained value creation. A vital goal of those in technology transfer, business development and investment roles if they are to base deals upon their IP and survive due diligence.

Panel

Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership, Clarivate
Chad Shear, Principal, Fish & Richardson
Emma Hodge, Small Pharma
Michael Murray, Murray International Partners Limited

By way of setting the scene you may want to check out the Scrip/Fish& Richardson Intellectual Property Sourcebook.

 

When
November 2nd, 2022 from  5:00 PM to  6:00 PM
Location
ONLINE - webinar details will be sent to all delegates closer to the date of the event
Cambridge, Cambridgeshire
United Kingdom
Contact
Phone: 01223 896450
Phone: 01223 896456